This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
optimal | control | 373 |
present | study | 209 |
- | time | 168 |
infectious | diseases | 161 |
- | control | 149 |
immune | system | 128 |
- | cell | 126 |
inflammatory | response | 124 |
immune | response | 122 |
high | levels | 81 |
infectious | disease | 77 |
first | time | 70 |
significant | . | 69 |
- | protein | 61 |
higher | levels | 56 |
- | treatment | 51 |
immune | responses | 51 |
- | level | 49 |
optimal | controls | 49 |
normal | . | 45 |
humans | . | 44 |
- | cells | 43 |
- | patient | 43 |
immune | cells | 40 |
low | levels | 40 |
total | protein | 40 |
others | . | 39 |
- | analysis | 38 |
- | days | 37 |
present | . | 37 |
- | response | 36 |
presented | . | 35 |
- | controlled | 35 |
inflammatory | responses | 35 |
clinical | disease | 34 |
respiratory | infections | 33 |
- | expression | 32 |
respiratory | system | 31 |
positive | cells | 30 |
effective | . | 29 |
high | level | 27 |
- | group | 27 |
- | day | 27 |
respiratory | infection | 26 |
low | . | 26 |
different | . | 25 |
high | . | 25 |
respiratory | disease | 25 |
- | infection | 24 |
first | day | 24 |
new | cases | 24 |
other | patients | 24 |
low | control | 24 |
first | study | 22 |
other | factors | 22 |
other | groups | 22 |
positive | control | 22 |
clinical | studies | 21 |
inflammatory | cells | 20 |
similar | results | 20 |
effective | treatment | 20 |
different | levels | 20 |
low | level | 20 |
other | . | 19 |
other | studies | 19 |
significant | effect | 19 |
lower | levels | 18 |
normal | controls | 18 |
positive | blood | 18 |
similar | . | 18 |
effective | control | 17 |
different | control | 16 |
important | . | 16 |
other | diseases | 16 |
high | control | 16 |
important | factors | 14 |
new | model | 14 |
positive | controls | 14 |
positive | effect | 14 |
severe | disease | 14 |
positive | effects | 13 |
first | group | 13 |
inflammatory | cell | 13 |
new | method | 13 |
different | cell | 13 |
acute | infection | 13 |
- | patients | 13 |
fetal | blood | 12 |
immune | cell | 12 |
inflammatory | diseases | 12 |
positive | . | 12 |
positive | results | 12 |
specific | genes | 12 |
lower | level | 11 |
specific | . | 11 |
severe | infection | 11 |
severe | cases | 11 |
clinical | study | 11 |
first | case | 11 |
different | groups | 11 |
acute | disease | 11 |
human | cells | 10 |
such | patients | 10 |
positive | cases | 10 |
positive | patients | 10 |
high | protein | 10 |
- | factor | 10 |
- | p | 10 |
different | times | 10 |
inflammatory | activity | 9 |
similar | effects | 9 |
respiratory | diseases | 9 |
normal | levels | 9 |
normal | level | 9 |
more | . | 9 |
new | patients | 9 |
important | factor | 9 |
human | diseases | 9 |
highest | level | 9 |
higher | level | 9 |
different | methods | 9 |
- | activity | 9 |
human | cases | 8 |
total | proteins | 8 |
severe | . | 8 |
presenting | cells | 8 |
other | cell | 8 |
new | infections | 8 |
inflammatory | effect | 8 |
human | disease | 8 |
effective | method | 8 |
human | blood | 8 |
first | days | 8 |
- | effects | 8 |
early | treatment | 8 |
different | time | 8 |
- | proteins | 8 |
- | mouse | 8 |
human | . | 8 |
present | results | 7 |
other | group | 7 |
other | proteins | 7 |
specific | treatment | 7 |
severe | infections | 7 |
specific | disease | 7 |
specific | time | 7 |
normal | mice | 7 |
other | cells | 7 |
other | genes | 7 |
lower | . | 7 |
inflammatory | disease | 7 |
infectious | . | 7 |
human | infection | 7 |
higher | . | 7 |
first | . | 7 |
effective | infection | 7 |
- | method | 7 |
inflammatory | effects | 7 |
presented | study | 6 |
normal | cells | 6 |
optimal | controlled | 6 |
optimal | treatment | 6 |
other | methods | 6 |
such | cases | 6 |
significant | effects | 6 |
specific | cell | 6 |
specific | model | 6 |
specific | protein | 6 |
more | time | 6 |
new | control | 6 |
immune | systems | 6 |
- | groups | 6 |
fetal | cells | 6 |
earlier | studies | 6 |
earlier | . | 6 |
different | effects | 6 |
clinical | response | 6 |
clinical | cases | 6 |
- | system | 6 |
- | studied | 6 |
- | effect | 6 |
highest | levels | 6 |
such | infections | 5 |
other | models | 5 |
other | patient | 5 |
specific | gene | 5 |
significant | factor | 5 |
such | studies | 5 |
total | control | 5 |
new | models | 5 |
other | mice | 5 |
more | cases | 5 |
new | infection | 5 |
high | blood | 5 |
- | factors | 5 |
clinical | effects | 5 |
different | diseases | 5 |
- | levels | 5 |
high | expression | 5 |
higher | expression | 5 |
infectious | patients | 5 |
normal | control | 4 |
similar | effect | 4 |
other | day | 4 |
other | systems | 4 |
present | studies | 4 |
severe | patients | 4 |
significant | expression | 4 |
significant | genes | 4 |
significant | results | 4 |
inflammatory | protein | 4 |
specific | cells | 4 |
specific | diseases | 4 |
specific | effect | 4 |
specific | expression | 4 |
such | mice | 4 |
such | results | 4 |
such | systems | 4 |
total | cell | 4 |
new | treatment | 4 |
normal | blood | 4 |
human | factor | 4 |
low | expression | 4 |
fetal | effects | 4 |
- | analyses | 4 |
- | disease | 4 |
- | mice | 4 |
acute | effects | 4 |
different | genes | 4 |
different | models | 4 |
different | proteins | 4 |
effective | methods | 4 |
clinical | expression | 4 |
higher | blood | 4 |
human | studies | 4 |
important | infection | 4 |
inflammatory | model | 4 |
infectious | patient | 4 |
inflammatory | activities | 4 |
inflammatory | genes | 4 |
normals | . | 3 |
other | disease | 3 |
other | controls | 3 |
other | control | 3 |
optimal | system | 3 |
new | system | 3 |
normal | cell | 3 |
new | treatments | 3 |
positive | response | 3 |
new | studies | 3 |
new | diseases | 3 |
new | disease | 3 |
other | infections | 3 |
different | patient | 3 |
present | case | 3 |
present | model | 3 |
present | time | 3 |
significant | factors | 3 |
similar | levels | 3 |
specific | activity | 3 |
specific | infections | 3 |
specific | proteins | 3 |
such | controls | 3 |
such | effects | 3 |
total | blood | 3 |
total | time | 3 |
lower | expression | 3 |
more | days | 3 |
- | genes | 3 |
low | protein | 3 |
different | days | 3 |
- | . | 3 |
- | blood | 3 |
- | case | 3 |
low | blood | 3 |
- | methods | 3 |
- | study | 3 |
- | systems | 3 |
- | times | 3 |
acute | cases | 3 |
clinical | responses | 3 |
clinical | results | 3 |
different | controls | 3 |
- | gene | 3 |
different | expression | 3 |
human | genes | 3 |
early | days | 3 |
inflammatory | factors | 3 |
important | effects | 3 |
human | infections | 3 |
important | results | 3 |
first | patient | 3 |
first | infection | 3 |
fetal | levels | 3 |
effective | response | 3 |
early | response | 3 |
other | effects | 2 |
new | case | 2 |
optimal | time | 2 |
optimal | response | 2 |
optimal | level | 2 |
optimal | blood | 2 |
normal | mouse | 2 |
new | protein | 2 |
new | patient | 2 |
new | level | 2 |
lowest | level | 2 |
new | blood | 2 |
more | systems | 2 |
more | studies | 2 |
more | groups | 2 |
more | blood | 2 |
lowest | . | 2 |
lower | control | 2 |
low | p | 2 |
other | treatment | 2 |
other | mouse | 2 |
inflammatory | gene | 2 |
other | treatments | 2 |
specific | cases | 2 |
total | group | 2 |
total | effect | 2 |
total | cells | 2 |
such | factors | 2 |
such | diseases | 2 |
such | cells | 2 |
specific | methods | 2 |
specific | infection | 2 |
similar | time | 2 |
positive | cell | 2 |
similar | result | 2 |
similar | response | 2 |
similar | models | 2 |
similar | model | 2 |
significant | time | 2 |
significant | group | 2 |
respiratory | control | 2 |
positive | study | 2 |
inflammatory | systems | 2 |
- | responses | 2 |
infectious | model | 2 |
early | time | 2 |
early | infection | 2 |
early | genes | 2 |
early | gene | 2 |
early | . | 2 |
earlier | study | 2 |
different | studies | 2 |
different | results | 2 |
different | protein | 2 |
different | cells | 2 |
different | cases | 2 |
clinical | patient | 2 |
clinical | factors | 2 |
clinical | effect | 2 |
clinical | diseases | 2 |
clinical | . | 2 |
acute | infections | 2 |
- | modelling | 2 |
- | infections | 2 |
important | model | 2 |
early | studies | 2 |
clinical | treatment | 2 |
effective | controls | 2 |
higher | results | 2 |
important | genes | 2 |
effective | time | 2 |
important | diseases | 2 |
immune | proteins | 2 |
immune | effects | 2 |
immune | . | 2 |
human | activity | 2 |
highest | expression | 2 |
human | protein | 2 |
higher | activity | 2 |
high | response | 2 |
high | p | 2 |
first | treatment | 2 |
first | results | 2 |
first | controlled | 2 |
higher | responses | 2 |
first | blood | 2 |
fetal | activity | 2 |
other | results | 1 |
positive | infections | 1 |
positive | responses | 1 |
positive | patient | 1 |
positive | mice | 1 |
others | studied | 1 |
positive | case | 1 |
others | studies | 1 |
other | times | 1 |
positive | studies | 1 |
positive | result | 1 |
presenting | groups | 1 |
positive | time | 1 |
positives | . | 1 |
present | control | 1 |
present | day | 1 |
presented | control | 1 |
presented | levels | 1 |
presented | results | 1 |
presenting | activity | 1 |
presenting | cell | 1 |
presents | patients | 1 |
presents | results | 1 |
other | infection | 1 |
other | model | 1 |
new | analysis | 1 |
other | cases | 1 |
other | case | 1 |
more | patient | 1 |
more | patients | 1 |
new | . | 1 |
new | activities | 1 |
severe | blood | 1 |
new | cell | 1 |
new | controls | 1 |
new | expression | 1 |
new | group | 1 |
new | methods | 1 |
new | mice | 1 |
new | systems | 1 |
non | protein | 1 |
normal | activity | 1 |
normal | gene | 1 |
normal | groups | 1 |
normal | response | 1 |
optimal | . | 1 |
optimal | effect | 1 |
optimal | levels | 1 |
optimal | treatments | 1 |
other | activity | 1 |
other | blood | 1 |
respiratory | . | 1 |
specific | activities | 1 |
severe | group | 1 |
specific | models | 1 |
specific | patient | 1 |
specific | response | 1 |
specific | responses | 1 |
specific | result | 1 |
specific | studies | 1 |
such | . | 1 |
such | activities | 1 |
such | control | 1 |
such | disease | 1 |
such | expression | 1 |
such | groups | 1 |
such | infection | 1 |
such | methods | 1 |
such | models | 1 |
such | mouse | 1 |
such | patient | 1 |
such | response | 1 |
such | responses | 1 |
such | study | 1 |
such | treatment | 1 |
total | . | 1 |
total | analysis | 1 |
total | cases | 1 |
specific | mouse | 1 |
specific | mice | 1 |
severe | groups | 1 |
specific | method | 1 |
severe | mouse | 1 |
severest | cases | 1 |
significant | cell | 1 |
significant | disease | 1 |
significant | infection | 1 |
significant | level | 1 |
significant | levels | 1 |
significant | model | 1 |
significant | p | 1 |
significant | response | 1 |
similar | cell | 1 |
similar | diseases | 1 |
similar | group | 1 |
similar | methods | 1 |
similar | patients | 1 |
similar | protein | 1 |
similar | studies | 1 |
similar | study | 1 |
more | effect | 1 |
specific | case | 1 |
specific | effects | 1 |
specific | group | 1 |
specific | level | 1 |
more | infections | 1 |
important | effect | 1 |
more | controls | 1 |
different | blood | 1 |
different | effect | 1 |
different | infection | 1 |
different | level | 1 |
different | method | 1 |
different | response | 1 |
different | responses | 1 |
different | studys | 1 |
different | systems | 1 |
different | treatment | 1 |
different | treatments | 1 |
earlier | methods | 1 |
earlier | treatment | 1 |
early | case | 1 |
early | disease | 1 |
early | results | 1 |
effective | activity | 1 |
effective | disease | 1 |
effective | level | 1 |
effective | model | 1 |
effective | p | 1 |
effective | results | 1 |
effective | system | 1 |
effective | systems | 1 |
different | disease | 1 |
different | activity | 1 |
fetal | cases | 1 |
different | activities | 1 |
- | activities | 1 |
- | controlling | 1 |
- | diseased | 1 |
- | diseases | 1 |
- | model | 1 |
- | studies | 1 |
- | timed | 1 |
- | treatments | 1 |
acute | blood | 1 |
acute | effect | 1 |
acute | patient | 1 |
acute | response | 1 |
acute | time | 1 |
clinical | activities | 1 |
clinical | activity | 1 |
clinical | analysis | 1 |
clinical | case | 1 |
clinical | groups | 1 |
clinical | infection | 1 |
clinical | infections | 1 |
clinical | levels | 1 |
clinical | model | 1 |
clinical | treatments | 1 |
effective | treatments | 1 |
fetal | cell | 1 |
more | control | 1 |
immune | disease | 1 |
immune | effect | 1 |
immune | mice | 1 |
important | blood | 1 |
important | disease | 1 |
important | methods | 1 |
important | protein | 1 |
important | result | 1 |
infectious | cases | 1 |
infectious | day | 1 |
inflammatory | . | 1 |
inflammatory | level | 1 |
inflammatory | mouse | 1 |
inflammatory | proteins | 1 |
inflammatory | system | 1 |
low | cell | 1 |
low | mouse | 1 |
lower | case | 1 |
lower | effect | 1 |
lower | mouse | 1 |
lower | time | 1 |
lowest | cell | 1 |
lowest | effects | 1 |
more | analyses | 1 |
immune | diseases | 1 |
human | study | 1 |
fetal | disease | 1 |
human | proteins | 1 |
fetal | gene | 1 |
fetal | response | 1 |
first | analysis | 1 |
first | control | 1 |
first | disease | 1 |
first | method | 1 |
first | result | 1 |
high | activity | 1 |
high | case | 1 |
high | disease | 1 |
high | effect | 1 |
high | groups | 1 |
high | mouse | 1 |
high | treatment | 1 |
higher | treatment | 1 |
highest | . | 1 |
highest | activity | 1 |
human | activities | 1 |
human | case | 1 |
human | cell | 1 |
human | gene | 1 |
human | levels | 1 |
human | patient | 1 |
total | study | 1 |